Skip to content

Research on Inheritance of Shi Xuemin's Antihypertensive Acupuncture Technique in the Treatment of Hypertension

Research on Inheritance of Shi Xuemin's Antihypertensive Acupuncture Technique in the Treatment of Hypertension

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004917
Enrollment
Unknown
Registered
2014-06-14
Start date
2014-07-24
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

the treatment group with medicine:acupuncture intervention
the control group with medicine:no acupuncture intervention
the treatment group without medicine:acupuncture intervention
the control group without medicine:without acupuncture intervention

Sponsors

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. For patients with no antihypertensive medication, systolic blood pressure should be more than 140 mmHg and/or diastolic blood pressure more than 90 mmHg based on 3 readings monitored at different days; 2. patients has been definitely diagnosed of primary hypertension for over 1 month; 3. Targeted blood pressure level has not been achieved with no antihypertensive medication or stable medication for over 1 month; 4. Age between 30 to 70 years old; 5. Patients have been fully informed, consent with the participation, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patient has been diagnosed of or suspicious of secondary hypertension; 2. Patient with acute stage cerebral infarction; 3. Women during pregnancy, lactation period, or childbearing age women with no contraceptive method; 4. Complicated with severe impairment of liver or renal function, disorder of mental or hematopoietic system; 5. Cutaneous infection at or near targeted acupoints location; 6. Patient participate in other clinical trial at present or within 1 month.

Design outcomes

Primary

MeasureTime frame
24hABPM;Immediate blood pressure;Blood pressure diar;

Secondary

MeasureTime frame
Principal syndrome of TCM integral;Quality of life questionnaire;Constitution in Chinese Medicine Questionnair;

Countries

China

Contacts

Public ContactXiaonong Fan
fanxiaonong@163.com+86 13902080823

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026